Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
AbstractThe necessary precondition for efficient boron neutron capture therapy (BNCT) is control over the content of isotope 10B in the tumor and normal tissues. In the case of boron-containing porphyrins, the fluorescent part of molecule can be used for quantitative assessment of the boron content. Study Objective: We performed a study of the biodistribution of the chlorin e6-Cobalt bis(dicarbollide) conjugate in carcinoma-bearing Balb/c mice using ex vivo fluorescence imaging, and developed a mathematical model describing boron accumulation and release based on the obtained experimental data. Materials and Methods: The study was performed on Balb/c tumor-bearing mice (CT-26 tumor model). A solution of the chlorin e6-Cobalt bis(dicarbollide) conjugate (CCDC) was injected into the blood at a dose of 10 mg/kg of the animal’s weight. Analysis of the fluorescence signal intensity was performed at several time points by spectrofluorimetry in blood and by laser scanning microscopy in muscle, liver, and tumor tissues. The boron content in the same samples was determined by mass spectroscopy with inductively coupled plasma. Results: Analysis of a linear approximation between the fluorescence intensity and boron content in the tissues demonstrated a satisfactory value of approximation reliability with a Spearman’s rank correlation coefficient of r = 0.938, p < 0.01. The dynamics of the boron concentration change in various organs, calculated on the basis of the fluorescence intensity, enabled the development of a model describing the accumulation of the studied compound and its distribution in tissues. The obtained results reveal a high level of correspondence between the model and experimental data. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Volovetsky, A.B.; Sukhov, V.S.; Balalaeva, I.V.; Dudenkova, V.V.; Shilyagina, N.Y.; Feofanov, А.V.; Efremenko, A.V.; Grin, M.A.; Mironov, A.F.; Sivaev, I.B.; Bregadze, V.I.; Maslennikova, A.V. Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma. Int. J. Mol. Sci. 2017, 18, 2556.
Volovetsky AB, Sukhov VS, Balalaeva IV, Dudenkova VV, Shilyagina NY, Feofanov АV, Efremenko AV, Grin MA, Mironov AF, Sivaev IB, Bregadze VI, Maslennikova AV. Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma. International Journal of Molecular Sciences. 2017; 18(12):2556.Chicago/Turabian Style
Volovetsky, Arthur B.; Sukhov, Vladimir S.; Balalaeva, Irina V.; Dudenkova, Varvara V.; Shilyagina, Natalia Y.; Feofanov, Аlexey V.; Efremenko, Anastasija V.; Grin, Mikhail A.; Mironov, Andrey F.; Sivaev, Igor B.; Bregadze, Vladimir I.; Maslennikova, Anna V. 2017. "Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma." Int. J. Mol. Sci. 18, no. 12: 2556.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.